Jämför metoder
Granska de valda metoderna sida vid sida; rader som skiljer sig är markerade.
| EORTC QLQ-LC13: Livskvalitet vid lungcancer× | EORTC QLQ-CX24: Livskvalitet vid livmoderhalscancer× | |
|---|---|---|
| Ämnesområde | Onkologi | Onkologi |
| Familj | Process / pipeline | Process / pipeline |
| Ursprungsår≠ | 1994 | 2006 |
| Upphovsperson≠ | Bergman, B., et al. (EORTC Quality of Life Group) | Greimel, E. R., et al. (EORTC Quality of Life Group) |
| Typ | Self-report questionnaire | Self-report questionnaire |
| Ursprungskälla≠ | Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗ | Greimel, E. R., Kuljanic Vlasic, K., Zwahlen, D., Rand, K., Heitz, U., Havsteen, H., et al. (2006). The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Acta Oncol, 45(3), 344–351. DOI ↗ |
| Alias | QLQ-LC13 | QLQ-CX24 |
| Närliggande | 5 | 5 |
| Sammanfattning≠ | The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials. | The EORTC QLQ-CX24 is a 24-item cervical-cancer-specific module designed to complement the EORTC QLQ-C30 core questionnaire. Developed by Greimel et al. in 2006, it measures sexual/vaginal function, body image, lymphedema, neuropathy, and gastrointestinal symptoms specific to cervical cancer and its treatments. It is the standard cervical cancer-specific QoL instrument in international oncology research. |
| ScholarGateDatamängd ↗ |
|
|